[go: up one dir, main page]

DE954994C - Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series - Google Patents

Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series

Info

Publication number
DE954994C
DE954994C DET9738A DET0009738A DE954994C DE 954994 C DE954994 C DE 954994C DE T9738 A DET9738 A DE T9738A DE T0009738 A DET0009738 A DE T0009738A DE 954994 C DE954994 C DE 954994C
Authority
DE
Germany
Prior art keywords
chlorophyll
metal complexes
production
compounds
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DET9738A
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANTON KALOJANOFF DIPL CHEM DR
MARTIN STRELL DIPL ING DR
Original Assignee
ANTON KALOJANOFF DIPL CHEM DR
MARTIN STRELL DIPL ING DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANTON KALOJANOFF DIPL CHEM DR, MARTIN STRELL DIPL ING DR filed Critical ANTON KALOJANOFF DIPL CHEM DR
Priority to DET9738A priority Critical patent/DE954994C/en
Application granted granted Critical
Publication of DE954994C publication Critical patent/DE954994C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41Porphyrin- or corrin-ring-containing peptides
    • A61K38/42Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Verfahren zur Herstellung von Komplex-Eiweißverbindungen der Metallkomplexe der Chlorophyll- und Porphyrin-Reihe Die Erfindung betrifft ein Verfahren zur Herstellung' von therapeutisch wertvollen Komplex-Eiweißverbindungen der Metallkomplexsalze der Chlorophyll- und Porphyrin-Reihen.Process for the production of complex-protein compounds of the metal complexes the chlorophyll and porphyrin series The invention relates to a process for the production ' of therapeutically valuable complex protein compounds of the metal complex salts of Chlorophyll and porphyrin series.

Im Patent 951 161 ist ein Verfahren zur Herstellung von komplexen Fibrinverbindungen der Metallkomplexe der Chlorophyll- und Porphyrin-Reihe beschrieben worden. Nach diesem Verfahren werden komplexe Fibrinverbindungen in der Weise erhalten, daß zu Frischblut lösliche Verbindungen der Metallkomplexe der Chlorophyll- und Ilorphyrin-Reihen zugesetzt werden.In the patent 951 161 is a method for the production of complex Fibrin compounds of the metal complexes of the chlorophyll and porphyrin series are described been. According to this process complex fibrin compounds are obtained in such a way that that soluble compounds of the metal complexes of chlorophyll and Ilorphyrin series can be added.

In weiterer Ausbildung dieses Verfahrens wird nunmehr erfindungsgemäß vorgeschlagen, Eiweißverbindungen insbesondere vom Typ der Albuminate bzw. Albuminosen zur Herstellung derartiger Verbindungen heranzuziehen.In a further development of this method is now according to the invention proposed protein compounds, in particular of the albuminate or albuminous type to use for making such connections.

Die in wasserlösliche Form übergeführten Eiweiße werden mit den löslichen Verbindungen der Metallkomplexe der Chlorophyll- und Porphyrin-Reihe versetzt und aus diesem Reaktionsgemisch die komplexen. Eiweißverbindungen durch Zusatz von geeigneten Eiweißfällungsmitteln, z. B. Alkohol, Aceton od. dgl., ausgefällt.The proteins converted into water-soluble form are mixed with the soluble ones Compounds of the metal complexes of the chlorophyll and porphyrin series added and from this reaction mixture the complex. Protein compounds through Addition of suitable protein precipitants, e.g. B. alcohol, acetone or the like., Precipitated.

Die anfallenden Verbindungen können in bekannter Weise isoliert und getrocknet werden, sie können aber auch unmittelbar therapeutische Verwendung finden.The resulting compounds can be isolated and in a known manner be dried, but they can also find direct therapeutic use.

Zur Durchführung des erfindungsgemäßen Verfahrens eignen sich alle Eiweiße, die schon in löslicher Form vorliegen oder zuvor in eine lösliche Form, sei es durch alkalische oder saure Behandlung, in die entsprechenden Natriumsalze übergeführt bzw. durch stufenweisen Abbau bis zu den Albuminosen abgebaut worden sind.All proteins which are already in soluble form or which have previously been converted into a soluble form, either by alkaline or acidic treatment, into the corresponding sodium salts or by gradual breakdown to albumin are suitable for carrying out the process according to the invention.

Nachstehend wird die Erfindung an Hand einiger Beispiele näher erläutert. Beispiel i Das im Schlachthof anfallende Frischblut wird zunächst mit einem gerinnungshemmenden Mittel, wie z. B. einem Gemisch von Phosphaten und Pyrophosphaten, behandelt und anschließend zur Entfernung der festen Formbestandteile zentrifugiert; zur weiteren Verarbeitung dient das Blutplasma.The invention is explained in more detail below with the aid of a few examples. Example i The fresh blood obtained in the slaughterhouse is first treated with an anticoagulant Means such as B. a mixture of phosphates and pyrophosphates, treated and then centrifuged to remove the solid mold components; to further The blood plasma is used for processing.

1,5 g Chlorin-es Kupfernatriumsalz werden zunächst in wenig Wasser gelöst und zu 2 1 Plasma unter gutem Rühren eingetragen. 1.5 g of chlorine-es copper sodium salt are first dissolved in a little water and added to 2 liters of plasma with thorough stirring.

Diesem Reaktionsgemisch gibt man unter gutem Rühren portionsweise 2 1 Aceton bei Zimmertemperatur zu.This reaction mixture is added in portions with thorough stirring 2 liters of acetone at room temperature.

Die anfallende komplexe Eiweiß-Chlorin-es Verbindung wird durch Filtration isoliert.The resulting complex protein-chlorin-es compound is filtered through isolated.

Die erhaltene Komplexverbindung wird gegebenenfalls im Vakuum getrocknet. Die Chlorin-e(,-Kupferkomponente ist in der entstehenden Komplexverbindung chemisch fest gebunden, so daß sie mit Wasser nicht mehr eluierbar ist. Beispiel e ioo g Labkasein werden durch Zusatz von Alkalien, z. B. verdünnter Natronlauge, in eine Natrium-Kaseinat-Lösung übergeführt. In diese Lösung gibt man unter gutem Rühren eine acetonische Lösung von 1,5 g Kupfer-Phäophytin. Das anfallende Produkt wird, wie oben beschrieben, weiterverarbeitet. Beispiel 3 In i 1 Eiklar wird eine wäßrige Lösung von 1,5 g Hämatoporphyrin-Fe-Komplex-Natriumsalz eingetragen. Die entstehende Komplexverbindung wird unter gutem Rühren mit i 1 Äthanol ausgefällt. Beispiel 4 i kg Haare werden in. der üblichen Weise, sei es durch Alkalien, sei es durch Säuren, so weit aufgeschlossen, daß das Haar soeben seine morphologische Struktur verloren hat und in Lösung gegangen ist. Diese Keratinlösung wird zunächst über Wolle filtriert, und in die anfallende klare Keratoselösung werden nunmehr io g eines Chlorin-ee Co-Komplex-Natriumsalzeseingetragen und, wie vorstehend beschrieben, ausgefällt und aufgearbeitet.The complex compound obtained is optionally dried in vacuo. The chlorin-e (, - copper component is chemical in the resulting complex compound firmly bound so that it can no longer be eluted with water. Example e ioo g Lab casein are obtained by adding alkalis, e.g. B. dilute caustic soda, in a Sodium caseinate solution transferred. It is added to this solution with thorough stirring an acetone solution of 1.5 g copper pheophytin. The resulting product is further processed as described above. Example 3 1 egg white becomes an aqueous one Added solution of 1.5 g of hematoporphyrin Fe complex sodium salt. The emerging The complex compound is precipitated with i 1 ethanol while stirring well. Example 4 i kg of hair are treated in the usual way, be it with alkalis or with acids, so open that the hair has just lost its morphological structure and has gone into solution. This keratin solution is first filtered through wool, and the resulting clear keratose solution now contains 10 g of a chlorine-ee Co-complex sodium salts are introduced and precipitated as described above and worked up.

Die erfindungsgemäßen Verbindungen eignen sich, wie bereits im Patent 951 161 beschrieben, als Haernostyptica. Sie enthalten ferner hervorragende Wirkungen bei der Proliferation und Stimulation des Gewebes und finden in vorteilhafter Weise Verwendung bei der Behandlung von Frischwunden.As in the patent, the compounds according to the invention are suitable 951 161, as Haernostyptica. They also contain excellent effects in the proliferation and stimulation of tissue and take place in an advantageous manner Use in the treatment of fresh wounds.

Die erfindungsgemäßen Verbindungen können somit in Form von Festsubstanzen unmittelbar Verwendung finden, sie können aber auch zur Herstellung von Pflastern, Salben, Pudern od. dgl. Medikamentfo-rmen dienen.The compounds according to the invention can thus be in the form of solid substances can be used directly, but they can also be used to make plasters, Ointments, powders or the like. Drug forms are used.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von Komplex-Eiweißverbindungen der Metallkomplexe der Chlorophyll- und Porphyrin-Reihe gemäß Patent 951 161, dadurch gekennzeichnet, daß in lösliche Eiweiße lösliche Verbindungen der Metallkomplexe der Chlorophyll- und Porphyrin-Reihen eingetragen und die entstehenden Komplex-Eiweißverbindungen in an sich bekannter Weise aufgearbeitet werden. PATENT CLAIM: Process for the production of complex-protein compounds of the metal complexes of the chlorophyll and porphyrin series according to patent 951 161, characterized in that compounds of the metal complexes of the chlorophyll and porphyrin series which are soluble in soluble proteins are entered and the resulting complex-protein compounds in an can be worked up in a known manner.
DET9738A 1954-07-15 1954-07-15 Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series Expired DE954994C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DET9738A DE954994C (en) 1954-07-15 1954-07-15 Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET9738A DE954994C (en) 1954-07-15 1954-07-15 Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series

Publications (1)

Publication Number Publication Date
DE954994C true DE954994C (en) 1956-12-27

Family

ID=7546186

Family Applications (1)

Application Number Title Priority Date Filing Date
DET9738A Expired DE954994C (en) 1954-07-15 1954-07-15 Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series

Country Status (1)

Country Link
DE (1) DE954994C (en)

Similar Documents

Publication Publication Date Title
AT390067B (en) METHOD FOR PRODUCING SUCCINYLATED PROTEINS
DE3888718T2 (en) Chemical derivatives of GHL-Cu.
DE954994C (en) Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series
DE1076888B (en) Process for the production of active substances that promote breathing for therapeutic purposes
AT214457B (en) Process for the production of complex protein compounds of the metal complexes of the chlorophyll and porphyrin series and their breakdown products
DE712564C (en) Process for purifying heparin solutions
DET0009738MA (en)
DE300513C (en)
DE488891C (en) Process for the preparation of N-substituted arsenobenzimidazolones
DE2002492A1 (en) Process for the production of sialoglobin sulfate
DE2654093A1 (en) METHOD FOR PRODUCING GELATINE
DE950594C (en) Method for obtaining heparin
AT213899B (en) Process for the preparation of the new 3- (p-Amino-benzenesulfonamido) -6-oxy-pyridazine and its salts
DE1084433B (en) Process for the production of pure solutions of the kallikrein inactivator
AT259763B (en) Process for the preparation of a pasteurized plasma protein solution
AT200257B (en)
DE743986C (en) Process for the production of proteolytic defense ferments
DE487199C (en) Process for the preparation of purified tuberculin preparations
DE701714C (en) Process for the production of durable water-soluble dry preparations of the circulatory hormone from pancreases of animals
DE708939C (en) Process for the production of gonadotropic hormones from aqueous starting solutions
DE694100C (en) Process for the production of metal compounds
DE1467773A1 (en) Polypeptide and method of making the same
DE378214C (en) Process for the production of protein degradation products
DE1230804B (en) Process for the preparation of pyridoxal-5-orthophosphoric acid ester
DE936205C (en) Process for obtaining the coferment of carbonic anhydrase